Hematopoietic engraftment of XLA bone marrow CD34⁺ cells in NOG/SCID mice

References

• Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006; 85(4)193–202
   PubMed Web of Science ®Google Scholar
• Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993; 361(6409)226–33
   PubMed Web of Science ®Google Scholar
• Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell. 1993; 72(2)279–90
   PubMed Web of Science ®Google Scholar
• Nomura K, Kanegane H, Karasuyama H, Tsukada S, Agematsu K, Murakami G, et al. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway. Blood. 2000; 96(2)610–7
   PubMed Web of Science ®Google Scholar
• Noordzij JG, de Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, de Groot R, et al. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children. Pediatr Res. 2002; 51(2)159–68
   PubMedGoogle Scholar
• Yang WC, Collette Y, Nunes JA, Olive D. Tec kinases: a family with multiple roles in immunity. Immunity. 2000; 12(4)373–82
   PubMed Web of Science ®Google Scholar
• Satterthwaite AB, Li Z, Witte ON. BTK function in B cell development and response. Semin Immunol. 1998; 10(4)309–16
   PubMed Web of Science ®Google Scholar
• Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ. Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity. 2000; 13(2)243–53
   PubMedGoogle Scholar
• Rawlings DJ, Saffran DC, Tsukada S, Largaespada DA, Grimaldi JC, Cohen L, et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science. 1993; 261(5119)358–61
   PubMed Web of Science ®Google Scholar
• Moreau T, Calmels B, Barlogis V, Michel G, Tonnelle C, Chabannon C. Potential application of gene therapy to X-linked agammaglobulinemia. Curr Gene Ther. 2007; 7(4)284–94
   PubMedGoogle Scholar
• Yu PW, Tabuchi RS, Kato RM, Astrakhan A, Humblet-Baron S, Kipp K, et al. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood. 2004; 104(5)1281–90
   PubMedGoogle Scholar
• Moreau T, Barlogis V, Bardin F, Nunes JA, Calmels B, Chabannon C, , et al Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA. Gene Ther. 2008.
   PubMedGoogle Scholar
• Kurosaka D, LeBien TW, Pribyl JA. Comparative studies of different stromal cell microenvironments in support of human B-cell development. Exp Hematol. 1999; 27(8)1271–81
   PubMedGoogle Scholar
• Berardi AC, Meffre E, Pflumio F, Katz A, Vainchenker W, Schiff C, et al. Individual CD34+CD38lowCD19−CD10− progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood. 1997; 89(10)3554–64
   PubMedGoogle Scholar
• Fluckiger AC, Sanz E, Garcia-Lloret M, Su T, Hao QL, Kato R, et al. In vitro reconstitution of human B-cell ontogeny: from CD34(+) multipotent progenitors to Ig-secreting cells. Blood. 1998; 92(12)4509–20
   PubMedGoogle Scholar
• Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995; 154(1)180–91
   PubMed Web of Science ®Google Scholar
• Lapidot T, Fajerman Y, Kollet O. Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J Mol Med. 1997; 75(9)664–73
   PubMed Web of Science ®Google Scholar
• Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood. 2007; 109(1)212–8
   PubMedGoogle Scholar
• Vorechovsky I, Vihinen M, de Saint Basile G, Honsova S, Hammarstrom L, Muller S, et al. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Hum Mol Genet. 1995; 4(1)51–8
   PubMedGoogle Scholar
• Wang JC, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 1997; 89(11)3919–24
   PubMed Web of Science ®Google Scholar
• Ellmeier W, Jung S, Sunshine MJ, Hatam F, Xu Y, Baltimore D, et al. Severe B cell deficiency in mice lacking the tec kinase family members Tec and BTK. J Exp Med. 2000; 192(11)1611–24
   PubMed Web of Science ®Google Scholar
• Espeli M, Rossi B, Mancini SJ, Roche P, Gauthier L, Schiff C. Initiation of pre-B cell receptor signaling: common and distinctive features in human and mouse. Semin Immunol. 2006; 18(1)56–66
   PubMedGoogle Scholar
• Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol. 2006; 18(1)20–30
   PubMedGoogle Scholar
• Prieyl JA, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci USA. 1996; 93(19)10348–53
   PubMedGoogle Scholar
• Uckun F, Ozer Z, Vassilev A. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress. Br J Haematol. 2007; 136(4)574–89
   PubMedGoogle Scholar
• Kersseboom R, Ta VB, Zijlstra AJ, Middendorp S, Jumaa H, Fokko van Loo P, et al. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement. J Immunol. 2006; 176(8)4543–52
   PubMedGoogle Scholar
• Tanabe H, Miyake K, Shimada T. HIV-mediated expression of Btk in hematopoietic stem cells is not sufficient to restore B cell function in X-linked immunodeficient mice. J Nippon Med Sch. 2005; 72(4)203–12
   PubMedGoogle Scholar
• Conley ME, Rohrer J, Rapalus L, Boylin EC, Minegishi Y. Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signaling in the human and the mouse. Immunol Rev. 2000; 178: 75–90
   PubMed Web of Science ®Google Scholar